日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

COLEC12high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling

COLEC12高表达的肿瘤相关巨噬细胞通过旁分泌NRG1-HER2/HER3信号通路调控肝细胞癌的乐伐替尼耐药性和癌症干细胞特性

Zhang, Jianxing; Qiao, Liang; Wu, Zongfeng; Zuo, Dinglan; Huang, Shanshan; Liu, Shaoru; Huang, Zhenkun; Zeng, Yi; Li, Yu; Yuan, Yichuan; Wang, Chenwei; He, Wei; Qiu, Jiliang; Yuan, Yunfei; Niu, Yi; Li, Binkui

Expert consensus regarding the clinical application of liver contrast-enhanced US with Sonazoid (Sonazoid CEUS)

关于使用 Sonazoid 进行肝脏对比增强超声检查(Sonazoid CEUS)临床应用的专家共识

Zhou, Jianhua; Li, Lingling; Yan, Kun; Zheng, Yuanyi; Jiang, Tian'An; Xu, Huixiong; Xu, Jingyong; Jing, Xiang; Ran, Haitao; Li, Yu; Cheng, Wen; Cui, Xin-Wu; Ding, Hong; Ding, Jianmin; Dong, Yi; Duan, Wenbin; Han, Hong; He, Guangzhi; He, Wei; Hu, Zhongqian; Huang, Ying; Li, Binkui; Li, Jie; Li, Kai-Yan; Li, Qian; Liu, Fangyi; Liu, Guang-Jian; Liu, Liping; Luo, Baoming; Luo, Wen; Luo, Yan; Lv, Ke; Meng, Xuan; Qiu, Li; Ren, Jie; Wang, Hongguang; Wang, Lijun; Wei, Xi; Wu, Wei; Xie, Xiao-Yan; Xing, Baocai; Xu, Dong; Yang, Hong; Yang, Jianhui; Yang, Meng; Yu, Jie; Yu, Ming-An; Yu, Xiaoling; Zheng, Wei; Zhou, Zu-Bang; Liang, Ping

USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma

USP14介导的代谢竞争会损害肝细胞癌中CD8+ T细胞的免疫监视功能。

Yuan, Yichuan; Niu, Yi; Huang, Zhenkun; Shi, Yunxing; Lin, Zhu; Zuo, Dinglan; Zhong, Chengrui; Li, Kai; Guan, Xin-Yuan; Yuan, Yunfei; Li, Binkui

Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.

调控因子 X1 通过转录调控 BECN1 促进索拉非尼诱导的肝细胞癌铁死亡

Yang Zhiwen, Yuan Yichuan, Niu Yi, Zuo Dinglan, Liu Wenwu, Li Kai, Shi Yunxing, Qiu Zhiyu, Li Keren, Lin Zhu, Zhong Chengrui, Huang Zhenkun, He Wei, Guan Xinyuan, Yuan Yunfei, Zeng Weian, Qiu Jiliang, Li Binkui

Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon's Perspective

不可切除肝细胞癌的全身治疗:外科医生的视角

Zhu, Xiao-Dong; Zhao, Lei; Li, Binkui; Cheng, Yuan; Sun, Hui-Chuan

Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial

乙型肝炎病毒相关肝细胞癌合并临床显著性门静脉高压患者的肝部分切除术与介入治疗:一项随机对照临床试验

Yuan, Yichuan; Peng, Hong; He, Wei; Zheng, Yun; Qiu, Jiliang; Chen, Bin; Zou, Ruhai; Wang, Chenwei; Lau, Wan Yee; Li, Binkui; Yuan, Yunfei

m(6)A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma

m(6)A介导的lnc-OXAR通过增强Ku70稳定性促进非酒精性脂肪性肝炎相关肝细胞癌的奥沙利铂耐药性

Lin, Zhu; Huang, Zhenkun; Qiu, Jiliang; Shi, Yunxing; Zuo, Dinglan; Qiu, Zhiyu; He, Wei; Niu, Yi; Yuan, Yunfei; Li, Binkui

Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study

对于最初无法切除的肝细胞癌患者,在转化治疗后获得放射学完全缓解,观察等待策略与手术切除策略的比较:一项倾向评分匹配的比较研究

Li, Binkui; Wang, Chenwei; He, Wei; Qiu, Jiliang; Zheng, Yun; Zou, Ruhai; Lin, Zhu; Shi, Yunxing; Yuan, Yichuan; Zhang, Rong; Zhang, Chao; Chen, Minshan; Lau, Wan Yee; Yuan, Yunfei

Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma

肝细胞癌中m6A修饰在免疫浸润、代谢和耐药性中的综合分析

Shi, Yunxing; Li, Kai; Yuan, Yichuan; Wang, Chenwei; Yang, Zhiwen; Zuo, Dinglan; Niu, Yi; Qiu, Jiliang; Li, Binkui; Yuan, Yunfei; He, Wei

PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinoma

PD-L1抑制剂与PD-1抑制剂联合贝伐单抗经血管介入治疗不可切除肝细胞癌的比较

Huang, Zhenkun; Chen, Tiejun; Li, Wenbin; Qiu, Jiliang; Liu, Shaoru; Wu, Zongfeng; Li, Binkui; Yuan, Yunfei; He, Wei